Assessing the Safety and Efficacy of AVX-012 in Subjects With Mild-to-moderate Dry Eye Syndrome
Clinical trial NCT03162094 · UNKNOWN
Trial details
- NCT number
- NCT03162094
- Sponsor
- Avizorex Pharma, S.L.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-03
- Primary completion
- 2018-12-01
- Enrollment
- 172
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.